{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:34:32Z","timestamp":1791858872041,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jaad.2014.06.036","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T23:45:17Z","timestamp":1406159117000},"page":"888-895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: Implications for genetic counseling"],"prefix":"10.1016","volume":"71","author":[{"given":"Miriam","family":"Potrony","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Anton","family":"Puig-Butill\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9990-6085","authenticated-orcid":false,"given":"Paula","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Badenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Malvehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1337-9745","authenticated-orcid":false,"given":"Susana","family":"Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2014.06.036_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1365-4362.1999.00712.x","article-title":"Melanoma and sun exposure: where are we now?","volume":"38","author":"Whiteman","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2014.06.036_bib2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejca.2004.10.015","article-title":"Meta-analysis of risk factors for cutaneous melanoma, I: common and atypical nevi","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaad.2014.06.036_bib3","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.ejca.2005.03.034","article-title":"Meta-analysis of risk factors for cutaneous melanoma, III: family history, actinic damage and phenotypic factors","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaad.2014.06.036_bib4","doi-asserted-by":"crossref","first-page":"7168","DOI":"10.1200\/JCO.2005.11.999","article-title":"Population-based analysis of prognostic factors and survival in familial melanoma","volume":"23","author":"Florell","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2014.06.036_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jmg.2006.043802","article-title":"Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents","volume":"44","author":"Goldstein","year":"2007","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaad.2014.06.036_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clindermatol.2008.09.005","article-title":"Melanoma and genetics","volume":"27","author":"Nelson","year":"2009","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2014.06.036_bib7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/jmedgenet-2012-101455","article-title":"Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants","volume":"50","author":"Puntervoll","year":"2013","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaad.2014.06.036_bib8","doi-asserted-by":"crossref","first-page":"9818","DOI":"10.1158\/0008-5472.CAN-06-0494","article-title":"High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL","volume":"66","author":"Goldstein","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2014.06.036_bib9","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/1097-0215(20000915)87:6<809::AID-IJC8>3.0.CO;2-U","article-title":"Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden)","volume":"87","author":"Vasen","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2014.06.036_bib10","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/jnci\/djs221","article-title":"Risk of non-melanoma cancers in first-degree relatives of\u00a0CDKN2A mutation carriers","volume":"104","author":"Mukherjee","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2014.06.036_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/(SICI)1097-0215(19991112)83:4<441::AID-IJC2>3.0.CO;2-R","article-title":"Characterization of ligurian melanoma families and risk of occurrence of other neoplasia","volume":"83","author":"Ghiorzo","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2014.06.036_bib12","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/92.15.1260","article-title":"High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families","volume":"92","author":"Borg","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2014.06.036_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s004390050642","article-title":"Inherited susceptibility to several cancers but absence of linkage between dysplastic nevus syndrome and CDKN2A in a melanoma family with a mutation in the CDKN2A (P16INK4A) gene","volume":"101","author":"Puig","year":"1997","journal-title":"Hum Genet"},{"key":"10.1016\/j.jaad.2014.06.036_bib14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1529-8019.2012.01499.x","article-title":"Genetic counseling in melanoma","volume":"25","author":"Badenas","year":"2012","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2014.06.036_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2009.03.016","article-title":"Selection criteria for genetic assessment of patients with familial melanoma","volume":"61","author":"Leachman","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.06.036_bib16","doi-asserted-by":"crossref","unstructured":"Ribes J, Esteban L, Cleries R, Galceran J, Marcos-Gragera R, Gispert R, et al. Cancer incidence and mortality projections up\u00a0to 2020 in Catalonia by means of Bayesian models. Clin Transl Oncol doi: 10.1007\/s12094-013-1140-z. Published online December 12, 2013.","DOI":"10.1007\/s12094-013-1140-z"},{"key":"10.1016\/j.jaad.2014.06.036_bib17","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaad.2014.06.036_bib18","first-page":"2995","article-title":"A novel p16INK4A transcript","volume":"55","author":"Mao","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2014.06.036_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/hmg\/7.2.209","article-title":"Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France; the French familial melanoma study group","volume":"7","author":"Soufir","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaad.2014.06.036_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/0471142905.hg0720s76","article-title":"Predicting functional effect of human missense mutations using PolyPhen-2","author":"Adzhubei","year":"2013","journal-title":"Curr Protoc Hum Genet"},{"key":"10.1016\/j.jaad.2014.06.036_bib21","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1038\/sj.onc.1204728","article-title":"A melanoma-associated germline mutation in exon 1beta inactivates p14ARF","volume":"20","author":"Rizos","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.jaad.2014.06.036_bib22","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.jid.5700094","article-title":"Population-based prevalence of CDKN2A mutations in Utah melanoma families","volume":"126","author":"Eliason","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2014.06.036_bib23","first-page":"490","article-title":"CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia","volume":"36","author":"Ruiz","year":"1999","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaad.2014.06.036_bib24","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/4.10.1845","article-title":"Mutations of the CDKN2\/p16INK4 gene in Australian melanoma kindreds","volume":"4","author":"Walker","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaad.2014.06.036_bib25","doi-asserted-by":"crossref","first-page":"E80","DOI":"10.1002\/hed.21911","article-title":"Novel germline CDKN2A mutation associated with head and neck squamous cell carcinomas and melanomas","volume":"35","author":"Cabanillas","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.jaad.2014.06.036_bib26","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1054\/bjoc.2001.1991","article-title":"CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation","volume":"85","author":"Della Torre","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaad.2014.06.036_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0994-15","article-title":"Germline p16 mutations in familial melanoma","volume":"8","author":"Hussussian","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2014.06.036_bib28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/jmedgenet-2011-100281","article-title":"CDKN2A is the main susceptibility gene in Italian pancreatic cancer families","volume":"49","author":"Ghiorzo","year":"2012","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaad.2014.06.036_bib29","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1365-2133.2009.09242.x","article-title":"CDKN2A mutations in melanoma families from Uruguay","volume":"161","author":"Larre Borges","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.06.036_bib30","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1365-2133.2011.10551.x","article-title":"Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma","volume":"165","author":"Nikolaou","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.06.036_bib31","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1200\/JCO.2005.08.034","article-title":"Role of the CDKN2A locus in patients with multiple primary melanomas","volume":"23","author":"Puig","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2014.06.036_bib32","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.0022-202X.2005.23931.x","article-title":"Recurrent patterns of dual RB and p53 pathway inactivation in melanoma","volume":"125","author":"Yang","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2014.06.036_bib33","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1038\/sj.onc.1207780","article-title":"BRAF alterations are associated with complex mutational profiles in malignant melanoma","volume":"23","author":"Daniotti","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.jaad.2014.06.036_bib34","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.jaad.2012.05.014","article-title":"Familial melanoma: clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a family","volume":"67","author":"Maubec","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.06.036_bib35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/gcc.1183","article-title":"Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect","volume":"32","author":"Auroy","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jaad.2014.06.036_bib36","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1755-148X.2008.00512.x","article-title":"CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma","volume":"21","author":"Pastorino","year":"2008","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2014.06.036_bib37","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1016\/j.canep.2011.07.007","article-title":"Clinical features predicting identification of CDKN2A mutations in Italian patients with familial cutaneous melanoma","volume":"35","author":"Pedace","year":"2011","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.jaad.2014.06.036_bib38","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1158\/1078-0432.CCR-08-0403","article-title":"Increased risk of cancer other\u00a0than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families","volume":"14","author":"de Snoo","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2014.06.036_bib39","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/ije\/24.3.504","article-title":"Associations between cigarette smoking and each of 21 types of cancer: a multi-site case-control study","volume":"24","author":"Siemiatycki","year":"1995","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jaad.2014.06.036_bib40","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/jnci\/djt023","article-title":"Active smoking and breast cancer risk: original cohort data and meta-analysis","volume":"105","author":"Gaudet","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2014.06.036_bib41","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/ejhg.2010.198","article-title":"Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling","volume":"19","author":"McWilliams","year":"2011","journal-title":"Eur J Hum Genet"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214016521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214016521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:31:15Z","timestamp":1759271475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962214016521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0190962214016521"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2014.06.036","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: Implications for genetic counseling","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2014.06.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}